Avinger Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.34
- Today's High:
- $0.44
- Open Price:
- $0.43
- 52W Low:
- $0.42
- 52W High:
- $1.95
- Prev. Close:
- $0.431
- Volume:
- 703725
Company Statistics
- Market Cap.:
- $6.40 million
- Book Value:
- -0.173
- Revenue TTM:
- $8.27 million
- Operating Margin TTM:
- -187.59%
- Gross Profit TTM:
- $2.65 million
- Profit Margin:
- -207.02%
- Return on Assets TTM:
- -37.25%
- Return on Equity TTM:
- -392.01%
Company Profile
Avinger Inc had its IPO on 2015-01-30 under the ticker symbol AVGR.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. Avinger Inc has a staff strength of 71 employees.
Stock update
Shares of Avinger Inc opened at $0.43 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.34 - $0.44, and closed at $0.36.
This is a -16.47% slip from the previous day's closing price.
A total volume of 703,725 shares were traded at the close of the day’s session.
In the last one week, shares of Avinger Inc have slipped by -23.08%.
Avinger Inc's Key Ratios
Avinger Inc has a market cap of $6.40 million, indicating a price to book ratio of 1.8341 and a price to sales ratio of 1.012.
In the last 12-months Avinger Inc’s revenue was $8.27 million with a gross profit of $2.65 million and an EBITDA of $-15266000. The EBITDA ratio measures Avinger Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Avinger Inc’s operating margin was -187.59% while its return on assets stood at -37.25% with a return of equity of -392.01%.
In Q1, Avinger Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Avinger Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-2.98 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Avinger Inc’s profitability.
Avinger Inc stock is trading at a EV to sales ratio of 0.9045 and a EV to EBITDA ratio of -0.4779. Its price to sales ratio in the trailing 12-months stood at 1.012.
Avinger Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $20.47 million
- Total Liabilities
- $20.66 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
Avinger Inc ended 2024 with $20.47 million in total assets and $0 in total liabilities. Its intangible assets were valued at $20.47 million while shareholder equity stood at $-1492000.00.
Avinger Inc ended 2024 with $0 in deferred long-term liabilities, $20.66 million in other current liabilities, 9000.00 in common stock, $-407020000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $10.37 million and cash and short-term investments were $10.37 million. The company’s total short-term debt was $15,792,000 while long-term debt stood at $0.
Avinger Inc’s total current assets stands at $17.68 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $1.01 million compared to accounts payable of $517000.00 and inventory worth $5.32 million.
In 2024, Avinger Inc's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Avinger Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.36
- 52-Week High
- $1.95
- 52-Week Low
- $0.42
- Analyst Target Price
- $1.6
Avinger Inc stock is currently trading at $0.36 per share. It touched a 52-week high of $1.95 and a 52-week low of $1.95. Analysts tracking the stock have a 12-month average target price of $1.6.
Its 50-day moving average was $0.64 and 200-day moving average was $0.86 The short ratio stood at 0.5 indicating a short percent outstanding of 0%.
Around 803.6% of the company’s stock are held by insiders while 1220% are held by institutions.
Frequently Asked Questions About Avinger Inc
Similar Industry Stocks (Medical Instruments & Supplies)
Most Active
Top Gainers
Top Losers
About
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company’s lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, including Ocelot and Tigereye, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is headquartered in Redwood City, California.